DaVita Inc.
Performance
株価チャート
業績・財務
業績・財務
| 売上高 | $3.42B |
| 営業利益 | $473.55M |
| 税引前利益 | $341.23M |
| 純利益 | $197.53M |
| 営業利益率 | 13.9% |
| ROE | -26.1% |
| ROA | 1.1% |
| 自己資本比率 | -4.3% |
| 総資産 | $17.50B |
| 純資産 | -$755.50M |
業績推移
売上・利益の推移
ROE・ROA の推移
詳細指標
詳細指標
| ROIC | — |
| ROE | 80.98% |
| ROA | 7.50% |
| FCFマージン | 7.23% |
| 粗利益率 | 32.45% |
| 営業利益率 | 13.86% |
| 営業CFマージン | 14.65% |
| 配当性向 | 0.00% |
| 配当成長率（3年） | — |
| Net Debt/EBITDA | 1261.33 |
| 実効税率 | — |
| 自社株買い傾向 | — |
バランスシート
バランスシート
| ネットキャッシュ | -$15.60B |
| NC比率 | -109.2% |
| 流動資産 | $4.06B |
| 有価証券 | $206.91M |
| 現金 | $644.24M |
| 負債総額 | $16.45B |
| 時価総額（BS時点） | $14.28B |
企業情報
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis dialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.
| ウェブサイト | https://www.davita.com |
| CEO | Mr. Javier J. Rodriguez |
| 従業員数 | 78,000人 |
| 住所 | 2000 16th Street, Denver, 80202, United States |
| 電話番号 | 720 631 2100 |
| 取引所 | NYQ |
| 国 | United States |